Pages that link to "Q30253926"
Jump to navigation
Jump to search
The following pages link to Hospital Universitario Severo Ochoa (Q30253926):
Displayed 50 items.
- Cristina Calvo (Q41274836) (← links)
- David Arroyo (Q56452001) (← links)
- Teodoro Del Ser (Q56844493) (← links)
- María Luz García-García (Q57334564) (← links)
- M. Llanos Carrasco Marina (Q57412131) (← links)
- José-Antonio Girón-González (Q59697554) (← links)
- Analysis of Soluble Mediators, Cytokines, and Circulating Angiogenic Factors (FACs) as Potential Predictors / Prognostic Factors in Advanced Non-squamous Lung Carcinoma (Q61909550) (← links)
- Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC (Q61981070) (← links)
- Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy (Q61981109) (← links)
- Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With R (Q63340580) (← links)
- Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy (Q63813754) (← links)
- Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor (Q63832834) (← links)
- Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. (Q63838101) (← links)
- Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy (Q64030268) (← links)
- GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States) (Q64123586) (← links)
- Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs (Q64351601) (← links)
- Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma (Q64392931) (← links)
- Multi-center Study of Residual Neuromuscular Block Incidence in the Post-anesthesia Care Unit (Q64603858) (← links)
- R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial (Q64655089) (← links)
- Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma (Q64655852) (← links)
- A 3 Year Follow-up Prospective Open Randomized Trial of TVT Versus Colposuspension for Primary Stress Incontinence (Q64710576) (← links)
- T790M Mutation Testing in Blood by Different Methodologies (Q64807328) (← links)
- Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old (Q65361017) (← links)
- Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone (Q65375955) (← links)
- Ciclophosphamide, Vincristine, Myocet and Prednisone, With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) Risk (Q65377050) (← links)
- Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients (Q65381718) (← links)
- Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) (Q65382372) (← links)
- Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation (Q65384017) (← links)
- ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients (Q65386101) (← links)
- Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) (Q65472914) (← links)
- Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV (Q65540504) (← links)
- Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children (Q66030680) (← links)
- EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan (Q66034391) (← links)
- Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient (Q66044284) (← links)
- Luis Rábago (Q67570179) (← links)
- Raul Gascuena (Q74292927) (← links)
- Javier González de Dios (Q79913802) (← links)
- María Del Carmen Méndez Díaz (Q80152951) (← links)
- María Martín-Mendez (Q83160917) (← links)
- Cristina Macía Villa (Q83538903) (← links)
- Francisco Jesús Merino Fernández (Q85469229) (← links)
- Luis Miguel Juarez Salcedo (Q87353299) (← links)
- Paz Collado (Q88309664) (← links)
- Artemio García-Escobar (Q89887269) (← links)
- Adolfo Ramos-Luengo (Q89928348) (← links)
- Pedro Vázquez-Jacinto (Q91529451) (← links)
- Almudena Alameda Cuesta (Q92655634) (← links)
- Alejandro Ordas Bayon (Q96254564) (← links)
- Enrique Sandoval (Q96254565) (← links)
- Sara Herrero-Jaén (Q98474359) (← links)